Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Acta Chir Plast ; 49(2): 37-9, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17684839

RESUMO

A two-stage, endoscopically assisted technique was used to reconstruct the chest wall and breast deformity in a female patient with Poland syndrome. In the first stage the latissimus dorsi muscle was transferred anteriorly, and a tissue expander was placed under the transposed muscle to adjust the size of the breast accordingly. In the second stage the same incision in the midaxillary line was used to remove the expander and place a permanent implant endoscopically. The two-stage technically demanding endoscopically assisted reconstruction of Poland syndrome was rewarded by inconspicuous scars and a fine aesthetic result.


Assuntos
Endoscopia , Procedimentos de Cirurgia Plástica/métodos , Síndrome de Poland/cirurgia , Adulto , Feminino , Humanos
2.
Microsurgery ; 20(2): 52-8, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10702737

RESUMO

The failure rate of replantations following a crush-avulsion type injury is high. This study has been designed to reproduce an effective standardized crush-avulsion injury model to the femoral artery of the rat and evaluate the antithrombotic efficacy of systemic intravenous administration of recombinant human tissue-type plasminogen activator (rt-PA). The crush-avulsion injury was reproduced by using a bulldog clamp and two hemostats and followed by microvascular repair. The animals were divided into three groups of 20 rats each and received either normal saline, heparin 100 U/kg body weight, or rt-PA 3.5 mg/kg body weight intravenously. Patency tests were performed 20 min and 48 h after blood flow reestablishment. Results showed that this experimental crush-avulsion injury model ensures low patency in the control group, whereas systemic rt-PA administration improves the patency rate statistically significantly compared to control and heparin groups at both 20 min and 48 h postrevascularization.


Assuntos
Fibrinolíticos/farmacologia , Microcirurgia , Ativador de Plasminogênio Tecidual/farmacologia , Grau de Desobstrução Vascular/efeitos dos fármacos , Procedimentos Cirúrgicos Vasculares , Animais , Modelos Animais de Doenças , Estudos de Avaliação como Assunto , Artéria Femoral/lesões , Humanos , Masculino , Distribuição Aleatória , Ratos , Ratos Wistar , Proteínas Recombinantes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA